Association between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study-Reference-Cited by-同舟云学术

Association between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study

Published:2022-04 Issue: Volume:166 Page:114-121
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Slimano Florian,Le Bozec Antoine,Cransac Amélie,Foucher Pascal,Lesauvage François,Delclaux Bertrand,Dory Anne,Mennecier Bertrand,Bertrand Benjamin,Gubeno-Dumon Marie-Christine,Dukic Sylvain,Mongaret Céline,Bouché Olivier,Hettler Dominique,Boulin Mathieu,Dewolf Maxime,Kanagaratnam Lukshe

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference53 articles.

1. ALIMTA: Summary of Product Characteristics [online]. Available from: https://www.ema.europa.eu/en/documents/product-information/alimta-epar-product-information_en.pdf (Accessed: September 2, 2021).

2. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial

3. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

4. Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089);Barlesi;J Clin Oncol,2013

5. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy;Hanna;J Clin Oncol,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Predictive factors associated with pemetrexed acute toxicity;European Journal of Clinical Pharmacology;2023-03-23

3. Drug–drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure;ESMO Open;2023-02

4. Side effects of gastrointestinal drugs;Side Effects of Drugs Annual;2023

5. Effect of Concomitant Proton Pump Inhibitors with Pazopanib on Cancer Patients: A Retrospective Analysis;Cancers;2022-09-28